An AI Platform for Designing Personalized Neoantigen Vaccines Which Induce Polyepitopic Immune Responses
Time: 10:30 am
day: Day Two
Details:
- Overview of a unique neoantigen discovery AI platform which integrates diverse experimental and prediction evidence
- Evaluating the immunogenicty of predicted neoantigens in a preclinical setting
- Demonstrating the induction of long-lasting, polyepitopic T-cell responses from personalized neoantigen vaccines in the ongoing TG4050 clinical trial
